Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Intravenous Lignocaine Infusion in VATS
NCT06289790Completed
- Start
- Apr 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection and lidocaine in postoperative pain (2 arms). Primary endpoints: Numerical Rating Scale for Pain at 24 hours and Cumulative Opioid Dose at 24 hours. Started Apr 2024; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionlidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06289790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289790.